GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (STU:7ZT) » Definitions » Interest Coverage

Hamlet BioPharma AB publ (STU:7ZT) Interest Coverage : 0 (At Loss) (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Hamlet BioPharma AB publ Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Hamlet BioPharma AB publ's Operating Income for the three months ended in Mar. 2025 was €-1.14 Mil. Hamlet BioPharma AB publ's Interest Expense for the three months ended in Mar. 2025 was €-0.00 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Hamlet BioPharma AB publ's Interest Coverage or its related term are showing as below:


STU:7ZT's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 117.6
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Hamlet BioPharma AB publ Interest Coverage Historical Data

The historical data trend for Hamlet BioPharma AB publ's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Hamlet BioPharma AB publ Interest Coverage Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - No Debt No Debt

Hamlet BioPharma AB publ Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt -

Competitive Comparison of Hamlet BioPharma AB publ's Interest Coverage

For the Biotechnology subindustry, Hamlet BioPharma AB publ's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamlet BioPharma AB publ's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's Interest Coverage falls into.


;
;

Hamlet BioPharma AB publ Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hamlet BioPharma AB publ's Interest Coverage for the fiscal year that ended in Jun. 2024 is calculated as

Here, for the fiscal year that ended in Jun. 2024, Hamlet BioPharma AB publ's Interest Expense was €0.00 Mil. Its Operating Income was €-3.77 Mil. And its Long-Term Debt & Capital Lease Obligation was €0.00 Mil.

Hamlet BioPharma AB publ had no debt (1).

Hamlet BioPharma AB publ's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Here, for the three months ended in Mar. 2025, Hamlet BioPharma AB publ's Interest Expense was €-0.00 Mil. Its Operating Income was €-1.14 Mil. And its Long-Term Debt & Capital Lease Obligation was €0.00 Mil.

Hamlet BioPharma AB publ did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Hamlet BioPharma AB publ  (STU:7ZT) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Hamlet BioPharma AB publ Interest Coverage Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines